Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03231150 · ClinicalTrials.gov registry record · NA
Plantar Fasciitis Randomized Clinical Control Trial
A NA study of Plantar Fascitis, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT03231150: Recruiting NA study of Plantar Fascitis, sponsored by University of Pennsylvania.
NCT03231150 is a NA study of Plantar Fascitis that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 62 participants, below the 87-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03231150, a NA study of Plantar Fascitis, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this clinical experiment is to compare, in terms of pain relief measured using the 10-cm visual analog scale (VAS) pain score (5-7), the clinical results of ultrasound-guided injection (USGI) versus anatomic topography-guided injection (ATGI) of corticosteroid for the treatment of proximal PF. Secondary aims will be to compare foot-related quality of life, as measured using the Foot Function Index (FFI)and the Bristol Foot Score (BFS), between the injection groups, and also to compare the pre-injection to late-term post-injection thickness of the plantar fascia as measured in the nested USGI group.
Primary Outcome
with the primary efficacy endpoint being the 3-month post injection pain score
Conditions Studied
Interventions
- PROCEDURE Local Steroid Injection into the plantar heel
- PROCEDURE Ultrasound Guided Injection
- PROCEDURE Anatomical Guided injection
Study Locations (1)
Pennsylvania
- Penn Presbyterian Medical Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2017-03-28 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
What NCT03231150 shows while recruiting
NCT03231150 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 87-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Plantar Fascitis appearing as the primary indexed condition, and to 3 interventions - of which Local Steroid Injection into the plantar heel is the first listed.
NCT03231150 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03231150 about?
NCT03231150 is a clinical study titled "Plantar Fasciitis Randomized Clinical Control Trial". The primary aim of this clinical experiment is to compare, in terms of pain relief measured using the 10-cm visual analog scale (VAS) pain score (5-7), the clinical results of ultrasound-guided injection (USGI) versus anatomic topography-guided injection (ATGI) of corticosteroid for the treatment of...
What is the current status of trial NCT03231150?
This trial is currently recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2017-03-28. Estimated completion is 2026-10-31.
What conditions does trial NCT03231150 study?
This clinical trial studies the following conditions: Plantar Fascitis.
What interventions are being tested in trial NCT03231150?
The interventions under investigation include: Local Steroid Injection into the plantar heel (PROCEDURE), Ultrasound Guided Injection (PROCEDURE), Anatomical Guided injection (PROCEDURE).
Who is sponsoring clinical trial NCT03231150?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03231150 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plantar Fascitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dynamic Versus Static Night Splinting of Plantar Fasciitis
RECRUITING · NA
-
HP Arize 3D Orthotics for Planar Fasciitis
ACTIVE NOT RECRUITING · NA
-
Shockwave Therapy for Plantar Fasciitis RCT
ACTIVE NOT RECRUITING · NA
-
Effects of Foot Rehabilitation And Minimalist Shoes on Pain, Strength, and Function in Adults With Plantar Fasciopathy
COMPLETED · NA
-
Effects of Exercise Versus Exercise and Instrument-Assisted Soft Tissue Mobilization for Plantar Fasciopathy Treatment
COMPLETED · NA
-
Acupuncture for Plantar Fasciosis in the Primary Care Setting
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
- NCT03904498 · 62 participants · Phase 2
COMT Inhibition Among Individuals With Comorbid AUD/ADHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI